July 20, 2020

Treatibles Debuts in Japan

Treatibles, a pioneer in functional hemp products for pets, is continuing its trail blazing tradition, becoming the first line of organic full spectrum hemp oil with naturally occurring CBD products for pets available in Japan that have gone through research and clinical trials.

Treatibles is currently available online in Japan with plans to expand to more than 1,000 stores in the near future.

“Treatibles is the only hemp-derived CBD product for pets currently available in Japan, in which clinical trials and research with pets were conducted in collaboration with universities and veterinarians prior to the product launch,” said Julianna Carella, Founder and CEO of Treatibles.

Treatibles was hand-selected by Takakura New Industries, a leader in developing and marketing natural pet products in Japan. Visit the Japanese website.

“Getting the Treatibles products approved for distribution in Japan meant finding great partners that could dedicate the necessary resources to this effort. We are thrilled to be working with such a respected distributor as Takakura New Industries,” Carella said.

“In order to consider and study CBD for pets in Japan, we researched a number of manufacturers in the United States where the CBD distribution is known to be extremely active,” said Kozi Kubota of Takakura.

“We chose to work with Treatibles for many reasons including their authenticity, product quality, variety of products, taste, verified benefits and more. Takakura New Industries is looking forward to working together with Treatibles to improve the well-being of small animals in Japan.”

Clinical trials were conducted by The Society of Animal CBD Research, led by Dr. Chie Mogi (Veterinary Medicine), Associate Professor, Faculty of Animal Nursing at Yamazaki University of Animal Nursing.

The Society was established in November 2019 for veterinarians and researchers to promote CBD research with small animals in Japan. Case studies continue to be conducted in cooperation with researchers of cannabinoids and veterinarians who are specifically interested in this field.


Subscribe to Pet Insight